# Reviva Labs Inc – FDA Inspection, Jun 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/reviva-labs-inc/d972556b-46de-4b0d-913c-1b115d43f6e6
Source feed: FDA_Inspections

> FDA inspection 1093699 of Reviva Labs Inc, June 21, 2019. Classification: No Action Indicated (NAI). 1 citation. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093699
- Company Name: Reviva Labs Inc
- Inspection Date: 2019-06-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1004786 - 2017-01-30](https://www.keypedia.com/records/fda_inspections/reviva-labs-inc/666990cb-87dd-4ac9-b43a-c1bc4d795494)
- [FDA Inspection 946855 - 2015-11-18](https://www.keypedia.com/records/fda_inspections/reviva-labs-inc/d2df837b-6b66-464e-9b0e-7b39cd19b4c8)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/devon-jenkins/cf47975b-987a-4672-9a37-135a4401b198)
- [FDA Associated Person](https://www.keypedia.com/people/nancy-m-espinal/f4494790-6a37-4998-853c-f859a0eb3330)

Company: https://www.keypedia.com/companies/reviva-labs-inc/ead80e21-c896-4dff-abea-77350b413f5c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c